These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 218105)

  • 1. Endorphins, lithium, and naloxone: their relationship to pathological and drug-induced manic-euphoric states.
    Gold MS; Byck R
    NIDA Res Monogr; 1978; (19):192-209. PubMed ID: 218105
    [No Abstract]   [Full Text] [Related]  

  • 2. [The possibility of endorphins playing a role in psychic disturbances].
    Emrich HM
    Arzneimittelforschung; 1978; 28(8):1270-3. PubMed ID: 223579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of naloxone on the activating effect on emotionally positive brain systems of substances that induce dependence].
    Evartau EE
    Farmakol Toksikol; 1980; 43(3):313-7. PubMed ID: 6256205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the opioid antagonist naloxone on human natural killer cell activity in vitro.
    Adelson MO; Novick DM; Khuri E; Albeck H; Hahn EF; Kreek MJ
    Isr J Med Sci; 1994 Sep; 30(9):679-84. PubMed ID: 8088979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and neuroendocrine effects of opioid receptor agonists in psychopathologic states.
    Judd LL; Risch SC; Segal DS; Janowsky DS; Huey LY
    Psychiatr Clin North Am; 1983 Sep; 6(3):393-402. PubMed ID: 6359090
    [No Abstract]   [Full Text] [Related]  

  • 6. Time series modeling of heroin and morphine drug action.
    Tschacher W; Haemmig R; Jacobshagen N
    Psychopharmacology (Berl); 2003 Jan; 165(2):188-93. PubMed ID: 12404073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic mediation of beta-endorphin-induced prolactin secretion.
    Van Loon GR; De Souza EB; Shin SH
    Neuroendocrinology; 1980 Oct; 31(4):293-6. PubMed ID: 6252497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment.
    Van Kammen DP; Murphy DL
    Psychopharmacologia; 1975 Nov; 44(3):215-24. PubMed ID: 1824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychomotor excitation caused by beta-endorphin: effect of rubidium and lithium].
    Beleslin DB; Samardzić R; Krstić SK; Mićić D; Terzić B
    C R Seances Soc Biol Fil; 1984; 178(4):387-91. PubMed ID: 6098349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of naloxone or beta-endorphin to affect pressure-induced tremor in guinea pig.
    Gilman SC; Ackerman MJ; Hallenbeck JM; Faden A
    Undersea Biomed Res; 1983 Jun; 10(2):89-93. PubMed ID: 6310841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone-induced endorphin dysfunction in addicts.
    Gold MS; Pottash AC; Extein I; Martin D; Kleber HD
    NIDA Res Monogr; 1982 Apr; 41():476-82. PubMed ID: 6289119
    [No Abstract]   [Full Text] [Related]  

  • 13. Behavioral effects of opioid receptor antagonists in psychopathologic states.
    Janowsky DS; Judd LL; Huey LY; Risch SC; Segal DS
    Psychiatr Clin North Am; 1983 Sep; 6(3):403-14. PubMed ID: 6316300
    [No Abstract]   [Full Text] [Related]  

  • 14. Are the endorphins involved in mediating the mood effects of ethanol?
    Ewing JA; McCarty D
    Alcohol Clin Exp Res; 1983; 7(3):271-5. PubMed ID: 6312829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol euphoria: possible mediation via endorphinergic mechanisms.
    Verebey K; Blum K
    J Psychedelic Drugs; 1979; 11(4):305-11. PubMed ID: 230360
    [No Abstract]   [Full Text] [Related]  

  • 16. Naltrexone in the treatment of opiate dependence.
    Resnick RB; Washton AM; Thomas MA; Kestenbaum RS
    NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective mu opioid is effective in mouse enteropooling model.
    Farmer SC; Burks TF
    Proc West Pharmacol Soc; 1991; 34():19-21. PubMed ID: 1664958
    [No Abstract]   [Full Text] [Related]  

  • 18. Lithium increases nerve growth factor levels in the rat hippocampus in an animal model of mania.
    Frey BN; Andreazza AC; Rosa AR; Martins MR; Valvassori SS; Réus GZ; Hatch JP; Quevedo J; Kapczinski F
    Behav Pharmacol; 2006 Jun; 17(4):311-8. PubMed ID: 16914949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of 3-methoxy-4-hydroxyphenylglycol in depressed patients: modifications by amphetamine and lithium.
    Beckmann H; van Kammen DP; Goodwin FK; Murphy DL
    Biol Psychiatry; 1976 Aug; 11(4):377-87. PubMed ID: 786381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of endogenous opioid systems in social behavior of individually-housed mice.
    Puglisi-Allegra S; Mele A; Cabib S
    Prog Clin Biol Res; 1984; 167():209-25. PubMed ID: 6095318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.